Eiger BioPharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Eiger BioPharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17% to $15,773,000. The net income raised on -$74,963,000 and profit margin reached -475%. Total operating expenses were $87,535,000.
Profit Margin
| 2014 | 0 | -33.85M | |
|---|---|---|---|
| 2015 | 0 | -44.41M | |
| 2016 | 0 | -47.08M | |
| 2017 | 0 | -42.44M | |
| 2018 | 0 | -52.39M | |
| 2019 | 0 | -73.64M | |
| 2020 | 0 | -68.63M | |
| 2021 | 12.14M | -33.91M | -279.34% |
| 2022 | 13.48M | -96.77M | -717.71% |
| 2023 | 15.77M | -74.96M | -475.26% |
EIGR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 15.77M | 13.48M | 12.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 24K | 1.83M | 745K | 645K | 486K | 54K | 41K | 23K | 11K | 0 |
Gross profit | 15.74M | 11.64M | 11.39M | -645K | -486K | -54K | -41K | -23K | -11K | 0 |
Operating exp. | ||||||||||
Research and development | 62.33M | 75.28M | 64.43M | 41.59M | 51.79M | 37.09M | 29.51M | 33.01M | 21.95M | 22.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 87.53M | 104.38M | 88.33M | 62.14M | 68.90M | 51.04M | 41.52M | 46.12M | 34.39M | 33.01M |
Operating income | -71.78M | -92.74M | -76.93M | -62.14M | -68.90M | -51.04M | -41.52M | -46.12M | -42.18M | -33.01M |
Other income (expenses), net | -3.17M | -4.01M | 43.08M | -2.90M | -1.34M | -12K | -928K | -277K | -2.23M | -835K |
Income before tax | -74.95M | -96.75M | -33.85M | -65.05M | -70.25M | -52.39M | -42.44M | -47.08M | -44.41M | -33.85M |
Income tax expense | 6K | 23K | 64K | 3.58M | 3.39M | 985K | 1.66M | 390K | 2.30M | -153K |
Net income | -74.96M | -96.77M | -33.91M | -68.63M | -73.64M | -52.39M | -42.44M | -47.08M | -44.41M | -33.85M |
Earnings per share | ||||||||||
Basic EPS | -50.78 | -69.74 | -0.98 | -2.3 | -3.01 | -3.84 | -4.86 | -5.63 | -35.11 | -21.62 |
Diluted EPS | -50.78 | -69.74 | -0.98 | -2.3 | -3.01 | -3.84 | -4.86 | -5.63 | -35.11 | -21.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |